Download Files:
Products Details
Product Description
– RIPK1-IN-3 (Example 38), a RIPK1 inhibitor, extracted from patent WO2018148626A1, possesses anti-inflammatory proprieties[1].
Web ID
– HY-126296
Shipping
– Room temperature
Applications
– COVID-19-immunoregulation
Molecular Formula
– C22H19F3N6O3
References
– [1]Guo Junqing, et al. Aminotriazolopyridines as kinase inhibitors. WO/2018/148626A1.
CAS Number
– 2242677-36-5
Molecular Weight
– 472.42
SMILES
– O=C(C1=CC(C2=CC3=NC(N)=NN3C=C2)=CN=C1OC)NC(C4=CC=CC=C4OC(F)(F)F)C
Clinical Information
– No Development Reported
Research Area
– Inflammation/Immunology
Solubility
– 10 mM in DMSO
Target
– RIP kinase
Isoform
– RIPK1
Pathway
– Apoptosis
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
